General information:
Reagents and solvents were purchased from commercial sources and used without further purification unless otherwise stated. When required, dried and deoxygenated solvents supplied by Sigma-Aldrich Solvent Purification System (SPS-200-6) were employed. Azobenzene equipped tetraurea calix [4] arene 1 was synthesised as previously described. *1 Thin-layer chromatography (TLC) was performed with DC-Alufolien Kieselgel 60 F254 (Merck). Silica gel 60A for chromatography (SDS) was employed in flash column chromatography. 1 H NMR, 13 C NMR, 31 P NMR, COSY, HSQC and HMBC spectra were recorded at 400 MHz using a Bruker 400 Ultrashield TM or a a 500 MHz Bruker Avance 500 Ultrashield TM spectrometer and glass J. Young NMR tubes. 31 P{ 1 H} NMR in integrable mode and DOSY experiments were performed in a 500 MHz Bruker Avance 500 Ultrashield TM spectrometer equipped with cryoprobe and J. Young glass NMR tubes. Mass Spectrometry experiments were performed on a LCT Premier, Waters-Micromass ESI or Autoflex, Bruker Daltonics MALDI. FT-IR measurements were carried out on a Bruker Optics ATR FTIR Alpha-p spectrometer equipped with a DTGS detector, KBr beam splitter at 4 cm -1 resolution. Melting points were measured in a Büchi Melting Point B-540 device with a 5 °C/min gradient. UV-Vis spectra were recorded on a Shimadzu UV-2401PC spectrophotometer.
Sample solution preparation:
Working solutions of 1 and 2 were prepared by directly weighting the required amount of solid into the NMR tube. All the solutions of 1 contain 0.80 ± 0.01 mg in a final volume of 0.5 ml of CD 2 Cl 2 (0.75 mM). In a similar way, all solutions of 2 contain 0.74 ± 0.01 mg in a final volume of 0.5 ml of CD 2 Cl 2 (0.75 mM). Solid samples were weighted in Mettler Toledo AX or MX/UMX microbalances with a resolution of 0.01 and 0.001 mg respectively. Guest stock solutions were prepared rubber-cap sealed vials, solved in CD 2 Cl 2 , with concentrations that would require the addition of ~50 μl of this stock solution to the NMR tube with the working sample (final volume 0.5 ml). The guest stock solutions were not employed for more than 3 days after their preparation. Polydimethylsyloxane was added as internal standard (δH = 0.1 ppm) to determine the changes in the integrals. In the final capsule-exchange experiments, methoxymethylbenzene was additionally added as internal standard (δH = 4.6 ppm; δH = 3.4 ppm) to control possible overlapping of the polydimethylsyloxane peak with included guest 5 signals.
Stimuli response experiments:
The target solution was prepared as explained above before sealing it in a J. Young NMR tube covered with foil and warm it up to 60 °C for 12h in an oil bath (in order to ensure the full conversion of tuC4A 1 into the "all-trans" (tttt) isomer). Then, the outside wall of the NMR tube was washed thrice with hexane in the dark to remove all the grease. The tubes were covered with foil until the experiments were recorded. NMR experiments were recorded without further treatment for the initial capsule samples. Then, UV irradiation was performed attaching (direct contact) the sample NMR tube to an UV lamp emitting at 365 nm (Vilber Loumar, France, 7mW/cm 2 ) using aluminium foil. NMR experiments were recorded after 1, 5, 10 and 15 minutes of UV irradiation for the guest release experiments or for 1, 3 and 7 minutes for the capsule exchange experiments.
The thermal treatments were performed by repeating the initial equilibration step after the UV-light irradiation.
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DOSY experiments:
DOSY experiments were performed in samples prepared as stated above and fixing the acquisition parameters to D20 = 0.1 s and P30 = 2 ms. Methyl 4-amino-2-(oct-7-en-1-yloxy)benzoate (6) was synthesised adapting a previously reported methodology. 4 NaH (60% in mineral oil) (1.00 g, 25 mmol, 1.05 equiv.) was carefully washed with hexanes (2x) under argon, before being suspended in anhydrous DMF (100 mL). Vacuum-dried methyl 4-amino-2-hydroxybenzoate (3.98 g, 23.81 mmol) was dissolved in anhydrous DMF (30 mL) and added drop-wise via syringe to the previous NaH suspension. A bubbler was connected to the flask, and once the hydrogen evolution stopped, 8-bromooctene (4.39 mL, 26.2 mmol, 1.1 equiv.) was added drop-wise. The mixture was stirred at 75 °C for 16 hours under argon atmosphere. Then, the solvent was removed by rotary evaporator and the crude mixture was partitioned between CH 2 Cl 2 and water. The CH 2 Cl 2 layer was washed with water (x2), and dried over Na 2 SO 4 . The solvent was evaporated and the resulting mixture was purified by column chromatography (Silica, CH 2 Cl 2 :Hexane:Et 2 O:Et 3 N (50:50:4:1)) to isolate a pale yellow oil (6.14 g, 93% yield). 
Methyl 4-(((4-nitrophenoxy)carbonyl)amino)-2-(oct-7-en-1-yloxy)benzoate (7)
was synthesised adapting a previously reported methodology. 4 Methyl 4-amino-2-(oct-7-en-1-yloxy)benzoate (6) (5.74 g, 20.70 mmol) was dissolved in a mixture CHCl 3 :THF (3:2). The reaction mixture was purged by bubbling argon and 4-nitrophenyl chloroformate (4.59 g, 22.76 mmol, 1.1 equiv.) was added. The reaction flask was equipped with a condenser and a silicone oil bubbler to allow the release of HCl. The reaction mixture was refluxed (85 °C) under argon for 20 hours. Then, the solvent was removed under vacuum. Then mixture was stirred in diethyl ether, filtered, washed with diethyl ether and dried to get an off-white solid (8.346 g, 91% yield). 
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NMR experiments:
Control experiments of single compounds: Figure S7 . 1 H NMR spectrum of tuC4A 1 in DCM-d 2 at 298K (400 MHz). Figure S12 . 1 H NMR spectrum of 1 and 2 (1:1 molar ratio) in DCM-d 2 at 298K (400 MHz). 
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Control experiments of non-capsular mixtures:
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Control experiments of capsular mixtures: Figure S18 . 1 H NMR spectrum of 1, 2 and 3 (1:1:1 molar ratio) in DCM-d 2 at 298K (400 MHz). 
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DOSY experiments: Figure S22 . 1 H pseudo-2D DOSY plot of 31·2 in DCM-d 2 at 298K (500 MHz). Calculated diffusion coefficients are given for the capsule and the solvent as an average with standard deviation.
The signal of the included guest (-0.9 ppm) has the same diffusion coefficient than the capsular assembly, indicating that is permanently forming part of the capsular system. Figure S23 . 1 H pseudo-2D DOSY plot of 52 2 in DCM-d 2 at 298K (500 MHz). Calculated diffusion coefficients are given for the capsule and the solvent as an average with standard deviation.
The signals of the included guest (0-1 ppm) have the same diffusion coefficient than the capsular assembly, indicating that is permanently forming part of the capsular system. Figure S35 . Study of the photostability of 5@2·2. Sequence of 1 H NMR spectra of 2 and 5 (1:0.5 molar ratio) (52 2 ) in DCM-d 2 at 298K (400 MHz) after UV (365 nm, 7mW/cm 2 ) irradiation for A) 0 min; B) 1 min; C) 5 min; D) 10 min; and E) 15 min. Thermal treatment of the last sample (12 h at 60 °C) did not change the last spectrum.
